|Bid||35.750 x 100|
|Day's Range||34.350 - 36.050|
|52 Week Range||17.250 - 36.050|
|PE Ratio (TTM)||19.23|
|Dividend & Yield||N/A (N/A)|
|1y Target Est||N/A|
A Relative Strength Rating upgrade for Ionis Pharmaceuticals shows improving technical performance. Will it continue?
Some smaller, more tightly-focused pharmaceutical stocks are outperforming the giants.
These three biotech equities have room to run.